Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
5 studies found for:    "Crigler-Najjar syndrome"
Show Display Options
Rank Status Study
1 Active, not recruiting Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)
Conditions: Urea Cycle Disorders,;   Crigler Najjar Syndrome
Intervention: Biological: HepaStem
2 Completed Orlistat Treatment of Crigler-Najjar Disease
Condition: Crigler-Najjar Syndrome
Intervention: Drug: orlistat
3 Active, not recruiting New Phototherapy Device to Treat Patients With Crigler-Najjar Disease
Conditions: Crigler Najjar Syndrome;   Children
Interventions: Device: Arm1 homemade phototherapy treatment;   Device: DRAP
4 Recruiting Immunity Against AAV in Crigler Najjar Patient
Condition: Crigler Najjar Syndrome
Intervention: Biological: Blood sample for immunology
5 Active, not recruiting Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)
Conditions: Urea Cycle Disorders,;   Crigler Najjar Syndrome
Intervention:

Indicates status has not been verified in more than two years